Doral, Florida Clinical Trials

A listing of Doral, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

This is a Phase 3, multicenter, open-label, pharmacokinetics (PK)/safety study.The study consists of 3 periods:Screening period: 2 to 4 weeks.Treatment period: 24 weeks.Post-intervention follow-up period: 16 weeks. The study duration will be approximately 42 to 44 weeks for each participant (including screening, treatment, and follow-up periods).The total number of planned …

Direct Helpers Research Center- Site Number : 8400015
 (4.4 away) Contact site
  • 0 views
  • 14 May, 2025
  • +5 other locations
A Study Evaluating JUV DERM VOLUMA XC Injectable Gel for Correction of Temple Hollowing in Adult Participants Over 22 Years Old

The objectives of this study are to evaluate the safety and effectiveness of Juvederm Voluma XC injectable gel in adult participants seeking correction of temple hollowing

Hevia Cosmetic Dermatology
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +14 other locations
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

University of Miami
 (9.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants  

Primary Objective: To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the administration of one dose in toddlers (Groups …

Investigational Site Number 8400047
 (0.0 away)
  • 0 views
  • 19 Feb, 2024
  • +31 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

headache
ly573144
migraine
preventive medication
lasmiditan
New Horizon Research Center
 (6.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
High-Speed Yoga and Executive Function

The purpose of this research study is to establish if a novel high-speed yoga program which incorporates visual cues can make a positive change in the participant's ability to make decisions and move as measured by several cognitive, balance and functional tests. It has been shown that yoga can improve …

cognitive assessment
cardiovascular disease
neuromuscular diseases
cancer
hoehn and yahr scale
Max Orovitz Laboratories
 (8.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)

The purpose of this study is to assess the hematologic effects of IMG-7289 therapy in ET and PV patients who require platelet, White Blood Cell (WBC) or Red Blood Cell (RBC) control, and have failed at least one standard therapy.

platelet count
polycythemia vera
fibrosis
neutrophil count
thrombocytopenia
University of Miami
 (9.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …

Driven Research- Site Number : 8400135
 (6.8 away) Contact site
  • 0 views
  • 29 Nov, 2025
  • +30 other locations
None

Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital
 (9.6 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +1 other locations
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.

rivastigmine
positron emission tomography
amyloidosis
memantine
donepezil
Optimus U
 (7.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations